BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, Rangaraju S, Seyfried NT. Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau. Neuropsychopharmacology 2021;46:98-115. [PMID: 32898852 DOI: 10.1038/s41386-020-00840-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Dwomoh L, Rossi M, Scarpa M, Khajehali E, Molloy C, Herzyk P, Mistry SN, Bottrill AR, Sexton PM, Christopoulos A, Conn J, Lindsley CW, Bradley SJ, Tobin AB. M 1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. Sci Signal 2022;15. [DOI: 10.1126/scisignal.abm3720] [Reference Citation Analysis]
2 Tonner H, Hunn S, Auler N, Schmelter C, Pfeiffer N, Grus F. Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma. IJMS 2022;23:13618. [DOI: 10.3390/ijms232113618] [Reference Citation Analysis]
3 Mofrad RB, Del Campo M, Peeters CFW, Meeter LHH, Seelaar H, Koel-Simmelink M, Ramakers IHGB, Middelkoop HAM, De Deyn PP, Claassen JAHR, van Swieten JC, Bridel C, Hoozemans JJM, Scheltens P, van der Flier WM, Pijnenburg YAL, Teunissen CE. Plasma proteome profiling identifies changes associated to AD but not to FTD. Acta Neuropathol Commun 2022;10:148. [PMID: 36273219 DOI: 10.1186/s40478-022-01458-w] [Reference Citation Analysis]
4 Maffioli E, Murtas G, Rabattoni V, Badone B, Tripodi F, Iannuzzi F, Licastro D, Nonnis S, Rinaldi AM, Motta Z, Sacchi S, Canu N, Tedeschi G, Coccetti P, Pollegioni L. Insulin and serine metabolism as sex-specific hallmarks of Alzheimer's disease in the human hippocampus. Cell Rep 2022;40:111271. [PMID: 36070700 DOI: 10.1016/j.celrep.2022.111271] [Reference Citation Analysis]
5 Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, Johnson ECB, Levey AI, Lah JJ, Roberts BR, Seyfried NT. Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Biomarker Proteins Reveals Stage-Specific Changes in Alzheimer’s Disease.. [DOI: 10.1101/2022.08.30.22279370] [Reference Citation Analysis]
6 Tippett LJ, Cawston EE, Morgan CA, Melzer TR, Brickell KL, Ilse C, Cheung G, Kirk IJ, Roberts RP, Govender J, Griner L, Le Heron C, Buchanan S, Port W, Dudley M, Anderson TJ, Williams JM, Cutfield NJ, Dalrymple-alford JC, Wood P; the NZ-DPRC. Dementia Prevention Research Clinic: a longitudinal study investigating factors influencing the development of Alzheimer’s disease in Aotearoa, New Zealand. Journal of the Royal Society of New Zealand. [DOI: 10.1080/03036758.2022.2098780] [Reference Citation Analysis]
7 Needham H, Torpey G, Flores CC, Davis CJ, Vanderheyden WM, Gerstner JR. A Dichotomous Role for FABP7 in Sleep and Alzheimer’s Disease Pathogenesis: A Hypothesis. Front Neurosci 2022;16:798994. [DOI: 10.3389/fnins.2022.798994] [Reference Citation Analysis]
8 Nelson RS, Dammer EB, Santiago JV, Seyfried NT, Rangaraju S. Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms. Front Neurosci 2022;16:902146. [DOI: 10.3389/fnins.2022.902146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Khoei TT, Ahajjam MA, Hu WC, Kaabouch N. A Deep Learning Multi-Task Approach for the Detection of Alzheimer’s Disease in a Longitudinal Study. 2022 IEEE International Conference on Electro Information Technology (eIT) 2022. [DOI: 10.1109/eit53891.2022.9813900] [Reference Citation Analysis]
10 Sun X, Sun H, Han X, Chen PC, Jiao Y, Wu Z, Zhang X, Wang Z, Niu M, Yu K, Liu D, Dey KK, Mancieri A, Fu Y, Cho JH, Li Y, Poudel S, Branon TC, Ting AY, Peng J. Deep Single-Cell-Type Proteome Profiling of Mouse Brain by Nonsurgical AAV-Mediated Proximity Labeling. Anal Chem 2022. [PMID: 35315655 DOI: 10.1021/acs.analchem.1c05212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mcfarland KN, Chakrabarty P. Microglia in Alzheimer’s Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis. Neurotherapeutics. [DOI: 10.1007/s13311-021-01179-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Vodičková A, Koren SA, Wojtovich AP. Site-specific mitochondrial dysfunction in neurodegeneration. Mitochondrion 2022:S1567-7249(22)00010-1. [PMID: 35182728 DOI: 10.1016/j.mito.2022.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Moncaster JA, Moir RD, Burton MA, Chadwick O, Minaeva O, Alvarez VE, Ericsson M, Clark JI, Mckee AC, Tanzi RE, Goldstein LE. Alzheimer's disease amyloid-β pathology in the lens of the eye. Experimental Eye Research 2022. [DOI: 10.1016/j.exer.2022.108974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Killinger BA, Marshall LL, Chatterjee D, Chu Y, Bras J, Guerreiro R, Kordower JH. In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain. Proc Natl Acad Sci U S A 2022;119:e2114405119. [PMID: 35082147 DOI: 10.1073/pnas.2114405119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
15 Jain M, Singh MK, Shyam H, Mishra A, Kumar S, Kumar A, Kushwaha J. Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders. Annals of Neurosciences. [DOI: 10.1177/09727531211070532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
16 Velásquez E, Szeitz B, Gil J, Rodriguez J, Palkovits M, Renner É, Hortobágyi T, Döme P, Nogueira FC, Marko-Varga G, Domont GB, Rezeli M. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease. Front Immunol 2021;12:750665. [PMID: 34712240 DOI: 10.3389/fimmu.2021.750665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Feng W, Yang J, Song W, Xue Y. Crosstalk between Heart Failure and Cognitive Impairment via hsa-miR-933/RELB/CCL21 Pathway. Biomed Res Int 2021;2021:2291899. [PMID: 34595235 DOI: 10.1155/2021/2291899] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Mol MO, Miedema SSM, van Swieten JC, van Rooij JGJ, Dopper EGP. Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics? Int J Mol Sci 2021;22:10298. [PMID: 34638637 DOI: 10.3390/ijms221910298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Uddin MS, Yu WS, Lim LW. Exploring ER stress response in cellular aging and neuroinflammation in Alzheimer's disease. Ageing Res Rev 2021;70:101417. [PMID: 34339860 DOI: 10.1016/j.arr.2021.101417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
20 Buccellato FR, D'Anca M, Fenoglio C, Scarpini E, Galimberti D. Role of Oxidative Damage in Alzheimer's Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery. Antioxidants (Basel) 2021;10:1353. [PMID: 34572985 DOI: 10.3390/antiox10091353] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
21 Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H, Dey KK, Chen PC, Yang K, Peng J. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 2021;16:55. [PMID: 34384464 DOI: 10.1186/s13024-021-00474-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 19.0] [Reference Citation Analysis]
22 Dwomoh L, Rossi M, Scarpa M, Khajehali E, Molloy C, Herzyk P, Mistry SN, Bottrill AR, Sexton PM, Christopoulos A, Conn PJ, Lindsley CW, Bradley SJ, Tobin AB. Activation of M1 muscarinic receptors reduce pathology and slow progression of neurodegenerative disease.. [DOI: 10.1101/2021.07.30.454298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Brockman AA, Mobley BC, Ihrie RA. Histological Studies of the Ventricular-Subventricular Zone as Neural Stem Cell and Glioma Stem Cell Niche. J Histochem Cytochem 2021;:221554211032003. [PMID: 34310246 DOI: 10.1369/00221554211032003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Khoei TT, Catherine Labuhn M, Caleb TD, Chen Hu W, Kaabouch N. A Stacking-based Ensemble Learning Model with Genetic Algorithm For detecting Early Stages of Alzheimer’s Disease. 2021 IEEE International Conference on Electro Information Technology (EIT) 2021. [DOI: 10.1109/eit51626.2021.9491904] [Reference Citation Analysis]
25 Jain AP, Sathe G. Proteomics Landscape of Alzheimer's Disease. Proteomes 2021;9:13. [PMID: 33801961 DOI: 10.3390/proteomes9010013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Xue D, Bush WS, Renton AE, Marcora EA, Bis JC, Kunkle BW, Boerwinkle E, Destefano AL, Farrer L, Goate A, Mayeux R, Pericak‐vance M, Schellenberg G, Seshadri S, Wijsman E, Haines JL, Blue EE, The Alzheimer's Disease Sequencing Project. Large‐scale sequencing studies expand the known genetic architecture of Alzheimer's disease. Alz & Dem Diag Ass & Dis Mo 2021;13. [DOI: 10.1002/dad2.12255] [Reference Citation Analysis]
27 Killinger B, Marshall L, Chatterjee D, Chu Y, Kordower J. Detection and Purification of Lewy Pathology from Formalin Fixed Primary Human Tissue Using Biotinylation by Antigen Recognition.. [DOI: 10.1101/2020.11.11.378752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ressler KJ, Williams LM. Big data in psychiatry: multiomics, neuroimaging, computational modeling, and digital phenotyping. Neuropsychopharmacology 2021;46:1-2. [PMID: 32919403 DOI: 10.1038/s41386-020-00862-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]